19 Best Induced Pluripotent Stem Cell Startups to Watch in 2025

The Definitive Seedtable Ranking of Induced Pluripotent Stem Cell Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 19 start-ups with an aggregate funding of $1.5b. The average funding per company in this subset is $79.2m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

9

Funding Rounds

$262.0m

Money raised

A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.

2

Funding Rounds

$114.0m

Money raised

Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.

3

Funding Rounds

$224.0m

Money raised

Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.

1

Funding Rounds

$9.9m

Money raised

Healios is a biotechnology company developing stem cell regenerative medicine therapies for the treatment of retinal and age-related macular diseases.

1

Funding Rounds

$10.4m

Money raised

Bone Therapeutics is a biotechnology company developing cell therapy treatments for orthopaedics and bone disease.

3

Funding Rounds

$157.3m

Money raised

TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.

3

Funding Rounds

$35.3m

Money raised

I Peace is a technology company that provides research and development services for GMP products, drug discovery, and personal iPSC banking.

Key people:

4

Funding Rounds

$229.0m

Money raised

Shoreline Biosciences, Inc. is a Cell-Based Immunotherapies founded in 2020 by Kleanthis G. Xanthopoulos.

Key people:

2

Funding Rounds

$22.5m

Money raised

Stemson Therapeutics is an iPSC Hair Loss Treatment founded by Geoff Hamilton.

2

Funding Rounds

$6.0m

Money raised

mRNA-based technology to develop engineered cell therapies for solid and liquid tumors

1

Funding Rounds

$16.0m

Money raised

Laverock Therapeutics is a skylark Therapeutics is now Laverock Therapeutics founded in 2022.

1

Funding Rounds

$87.0m

Money raised

Clade Therapeutics is a stem Cell Therapies founded by Jim Glasheen, Chad Cowan and Leandro Vetcher.

2

Funding Rounds

$63.0m

Money raised

Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure

2

Funding Rounds

$44.0m

Money raised

Vita Therapeutics is a company founded in 2018.

2

Funding Rounds

$122.0m

Money raised

Neurophth Therapeutics is an ophthalmology Gene Therapy.

1

Funding Rounds

$85.0m

Money raised

Notch Therapeutics is a gene-modified T cell therapy.

1

Funding Rounds

$11.2m

Money raised

Greenstone is a platform computational biology startup company at Stanford Research Park, located at Alexandria Center for Life Sciences.

1

Funding Rounds

$590.0k

Money raised

Developer of stem cell-based therapies for vision restoration.

1

Funding Rounds

$5.0m

Money raised

RYNE Biotechnology Inc. is an iPSC dopamine progenitor founded in 2022.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.